The PCI Center

Filter Your Results

 

News

 

Clinical Study of Medtronic's Resolute Onyx 2.0-mm DES for Extra Small Vessels Meets Primary Endpoint

May 18, 2017 -- Medtronic announced that the Resolute Onyx 2.0-mm drug-eluting stent (DES) met its primary endpoint of target lesion failure (TLF) at 1 year for the treat…

Biotronik's Magmaris Resorbable Scaffold Shows Reduced Risk of Thrombosis

May 17, 2017 -- Biotronik announced data demonstrating that the company's Magmaris resorbable scaffold offers a reduced risk of thrombus formation compared with a polymeri…

Study Evaluates Performance of Acist's Navvus Microcatheter for FFR

May 17, 2017 -- Acist Medical Systems Inc., a Bracco Group Company, announced results from the ACIST-FFR study demonstrating the consistent and correlative performan…

Micell's MiStent Achieves Primary Endpoint in All-Comers DESSOLVE III Trial

May 16, 2017 -- Micell Technologies, Inc. announced that positive 12-month data from its DESSOLVE III clinical trial were presented by Prof. Robbert J. de Winter, MD, dur…

Three-Year Safety and Efficacy Data Presented From ABSORB China and ABSORB Japan

May 16, 2017 -- Abbott Vascular announced that results from two randomized clinical studies of the company's fully dissolving Absorb coronary stent showed comparable safet…

Cordis Introduces PCI Devices at EuroPCR

May 15, 2017  -- Cordis, Cardinal Health’s interventional vascular business, announced the commercial launch of three new products that further enhance its interve…

Shockwave Medical's Coronary Lithoplasty System Receives CE Mark Approval

May 15, 2017 -- Shockwave Medical, Inc. announced European CE Mark approval for the company’s coronary Lithoplasty system for the treatment of calcified p…

Analyses of PLATINUM Diversity Trial Evaluates PCI Outcomes for Underrepresented Populations

May 12, 2017 -- Boston Scientific Corporation announced that new analyses from the company-sponsored PLATINUM Diversity study underscore the need for greater understandin…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.